Growth Hormone Insensitivity Syndrome (GHIS) Completed Phase 2 / 3 Trials for rhIGFBP-3 (DB05897)

Also known as: Growth Hormone Insensitivity Syndrome

IndicationStatusPhase
DBCOND0036023 (Growth Hormone Insensitivity Syndrome (GHIS))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00368173IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron SyndromeTreatment